Business Development at SurModics

As a leader in surface modification and drug delivery solutions for the healthcare industry, SurModics is committed to providing our customers with the world's foremost innovative technologies and products. To support the Company's mission, SurModics is actively seeking to acquire, in-license, jointly develop or invest in complementary external technologies and products.  Products and technologies of interest include:

 
  • Biomaterials-based technologies and products with potential applications in surface modification or drug delivery (site-specific or systemic)
  • Devices or medical products utilizing advanced biomaterials and/or controlled release technology
  • Drug-device combination products
  • Products, tools and technologies for potential applications in the in vitro diagnostics, genomics/proteomics and cell-based discovery markets


SurModics offers deep experience and resources as a value-creating interface

SurModics has a proven track record of bringing new products expeditiously from concept to successful commercialization.  We have extensive scientific expertise and strong technical and business capabilities to evaluate and assimilate new technologies and innovations. Furthermore, we have established a broad customer base in the medical device, pharmaceutical and biotechnology industries through our numerous relationships with companies ranging from small start-ups to global industry leaders.  Additionally, our strong balance sheet allows us to be flexible in our business development transaction structures. Because of these distinctive strengths and capabilities, SurModics can serve as the unique value-creating interface between your innovations and potential customers. SurModics can also serve as the enabling link between pharmaceutical/biotech companies and medical device companies to create breakthrough drug/device combination products. Bringing complementary innovations and capabilities together significantly increases the likelihood of commercialization success and value creation in a timely manner.


Flexible business development process and structures
SurModics understands the importance of these key relationships, and we have a strong respect for confidentiality and business ethics. We are committed to being responsive to our partners' needs and timelines.  Recognizing that each relationship is unique, we are creative in devising business structures to suit your specific needs.  Our ultimate goal is to create significant value for both parties.


Structures employed in previous SurModics business development transactions include:

 
  • Technology in-licensing or acquisition
  • Joint technology/product development
  • Strategic alliance
  • Strategic investment
  • Merger or acquisition


Examples of existing strategic relationships with SurModics include:

 
  • Collaboration with Paragon Intellectual Properties on the development of a novel stent system incorporating our Finale™ Prohealing coating technology for the treatment of coronary artery disease
  • Collaboration with Donaldson and Corning Life Sciences on synthetic ECM cell culture products
  • Joint development of drug-device convergence products to treat diseases of the prostate with AbbeyMoor Medical
  • Collaborations with InnoCore and OctoPlus on the application of biodegradable polymers for use in drug-eluting medical device applications
  • Collaboration with Novocell on islet cell encapsulation for diabetes treatment
  • Collaborations with and/or licenses from academic institutions such as the University of Arizona


Examples of other types of transactions performed by SurModics include:

 
  • Acquisition of BioFX Laboratories, a provider of substrates to the in vitro diagnostics industry
  • Acquisition of Brookwood Pharmaceuticals, a leading provider of drug delivery technology primarily to the pharmaceutical industry
  • Acquisition of InnoRx, a company in the field of ophthalmic drug delivery
  • Acquisition of intellectual property covering biodegradable polymer technology from Intralytix
  • Investments in Paragon, ThermopeutiX, OctoPlus, and Novocell


Contact Form

You may submit your inquiry or proposal using the Contact Form.


Note:
Information disclosed online is not submitted in confidence, nor does it imply any agreement for compensation or to enter into a binding business relationship. If you would like to submit an idea, proposal, or business plan in confidence, please contact us to first establish a Confidentiality Agreement.

SurModics, Inc.
9924 West 74th Street
Eden Prairie, MN 55344-3523
USA

Toll Free: 866-787-6639
Phone: 952-829-2700
Fax: 952-829-2743

Contact Form